About Novavax

Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Using innovative proprietary recombinant nanoparticle vaccine technology, we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. More...

Investors

Novavax is traded on the Nasdaq Stock Market under the symbol NVAX and is dedicated to developing novel vaccines to address infectious disease. More...

NOVAVAX’ recombinant protein
nanoparticle vaccine technology

NOVAVAX’ maternal immunization
RSV vaccine candidate

NOVAVAX AWARDS